Author

Julia An

Columbia University Irving Medical CenterPrimary ORCID profile (0000-0003-2029-0335 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Julia AniD1 paper · Johns Hopkins University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

Amelia Van Aelst· 1 shared Anil Rustgi· 1 shared Anna M. ChiarellaiD· 1 shared Aparna Krishnan· 1 shared Benjamin IzariD· 1 shared Bret TabackiD· 1 shared Brian E. Ragaishis· 1 shared Bridget LittsiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Amelia Van Aelst

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Cardiovascular Benefit of Menopause Hormone Treatment is Age-Dependent in Ldlr-/- Mice

Cassandra D. Lalisan, Connor Gavin, Bridget Litts, Min Zhong, Jeffrey A. Rein, Julia An, Rajguru Boobalan, Yu Wang, Amelia Van Aelst, Sivaprakasam Chinnarasu, Yaomin Xu, MacRae F. Linton, John M. Stafford, Lin Zhu

This study shows that menopause hormone treatment (E2) reduces atherosclerosis in young mice but not older mice, due to age-related changes in inflammation and estrogen receptor signaling.

bioRxiv · Oct 27, 2026 · PreprintPhysiology

Targeting CD73-A2aR-Mediated Adenosine Signaling at the Tumor-Immune Interface Overcomes Radioresistance

Shruti Bansal, Luis Aparicio, Aparna Krishnan, Chang Liu, Lindsay Caprio, Anna M. Chiarella, Samanta Sarti, Jason Piersant, Chelsea L. Rahiman, Julia An, Patrick McCann, Namita Sen, Brian E. Ragaishis, Fatemeh N. Derakhshan, Bret Taback, , Catherine S. Spina

This study shows that targeting CD73-A2aR adenosine signaling with radiotherapy and checkpoint inhibitors improves tumor control by overcoming radioresistance and enhancing antitumor immunity.

bioRxiv · May 29, 2026 · PreprintCancer Biology